[Congressional Record Volume 143, Number 160 (Thursday, November 13, 1997)]
[Senate]
[Page S12616]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




SENATE CONCURRENT RESOLUTION 69--CORRECTING THE ENROLLMENT OF THE BILL 
                                 S. 830

  Mr. JEFFORDS submitted the following concurrent resolution; which was 
considered and agreed to.
       Resolved by the Senate (the House of Representatives 
     concurring), That, in the enrollment of the bill (S. 830) to 
     amend the Federal Food, Drug, and Cosmetic Act and the Public 
     Health Service Act to improve the regulation of food, drugs, 
     devices, and biological products, and for other purposes, the 
     Secretary of the Senate shall make the following corrections:
       (1) In section 119(b) of the bill:
       (A) Strike paragraph (2) (relating to conforming 
     amendments).
       (B) Strike ``(b) Section 505(j).--'' and all that follows 
     through ```(3)(A) The Secretary shall'' and insert the 
     following:
       ``(b) Section 505(j).--Section 505(j) (21 U.S.C. 355(j)) is 
     amended by adding at the end the following paragraph:
       ```(9)(A) The Secretary shall''.
       (2) In section 125(d)(2) of the bill, in the matter 
     preceding subparagraph (A), insert after ``antibiotic drug'' 
     the second place such term appears the following: 
     ``(including any salt or ester of the antibiotic drug)''.
       (3) In section 127(a) of the bill: In section 503A of the 
     Federal Food, Drug, and Cosmetic Act (as proposed to be 
     inserted by such section 127(a)), in the second sentence of 
     subsection (d)(2), strike ``or other criteria'' and insert 
     ``and other criteria''.
       (4) In section 412(c) of the bill:
       (A) In subparagraph (1) of section 502(e) of the Federal 
     Food, Drug, and Cosmetic Act (as proposed to be amended by 
     such section 412(c)), in subclause (iii) of clause (A), 
     insert before the period the following: ``or to prescription 
     drugs''.
       (B) Strike ``(c) Misbranding.--Subparagraph (1) of section 
     502(e)'' and insert the following:
       ``(c) Misbranding.--
       ``(1) In general.--Subparagraph (1) of section 502(e)''.
       (C) Add at the end the following:
       ``(2) Rule of construction.--Nothing in this Act, or the 
     amendments made by this Act, shall affect the question of the 
     authority of the Secretary of Health and Human Services 
     regarding inactive ingredient labeling for prescription drugs 
     under sections of the Federal Food, Drug, and Cosmetic Act 
     other than section 502(e)(1)(A)(iii).''.
       (5) Strike section 501 of the bill and insert the 
     following:

     ``SEC. 501. EFFECTIVE DATE.

       ``(a) In General.--Except as otherwise provided in this 
     Act, this Act and the amendments made by this Act shall take 
     effect 90 days after the date of enactment of this Act.
       ``(b) Immediate Effect.--Notwithstanding subsection (a), 
     the provisions of and the amendments made by sections 111, 
     121, 125, and 307 of this Act, and the provisions of section 
     510(m) of the Federal Food, Drug, and Cosmetic Act (as added 
     by section 206(a)(2)), shall take effect on the date of 
     enactment of this Act.''.

                          ____________________